Deutsch Español Français Italiano Português Pусский العربية 日本語 한국의 中文
>>Product>>Adefovir Dipivoxil
No.:
9
English_Name:
Adefovir Dipivoxil
English_Synonyms:
BIS POM PMEA;BIS(PIVALOYLOXYMETHYL)-9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE;9-[2-[bis[(pivaloyloxy)methoxy]phosphinyl]methoxy]ethyl]adenine;ADEFOVIR DIPIVOXIL;ADEFOVIR PIVOXIL;Adefovir Dipivoxyl;Bis(Pivaloyloxymethyl)-9-[(R)-2-(Phosphonomethoxy)Ethyl]Adenine;AdefovirDipivoxl98.5%Min;Adefovir Dipivoxl;ADEFOVIR DIPVOXIL;ADEFOVIR DIPIVOLIX;ADEFOVIR;Adefovir Dipivoxi;9-(2[bis(Pivaloyloxymethoxy)phosphorylmethoxy]ethyl)adenin
CAS No:
142340-99-6
Formula:
C20H32N5O8P
Molecular_Weight:
501.47
Molecular_Structure:
北京靖源医药产品图片
Appearance:
White or off-white crystalline powder
Standard:
Enterprise Standard
Assay:
≥99.5%
Package:
25kg/Drum
Use:
With broad-spectrum anti-viral activity, can be used for chronic hepatitis B treatment.

Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.

This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Section 68B of the Patents Act of 1953 in New Zealand; (vi) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (vii) such similar laws and rules as may apply in various other countries.

Not available in some countries; not available to some institutions; not available for some uses.